コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ignition and producing warm dense matter for basic science.
2 lanar superconducting tunnelling studies for basic science.
3 relevance to biomedicine, biotechnology and basic science.
4 cy to fund edge science is mostly limited to basic science.
5 avigation, communication, remote sensing and basic science.
6 cit is a key challenge for both clinical and basic science.
7 re less likely to be published compared with basic science.
8 uantitative and qualitative cell analysis in basic science.
9 k is needed for translational as well as for basic science.
10 n spectroscopy, communication, metrology and basic science.
11 n from those direct clinical translations of basic science.
12 for improving biostatistics education in the basic sciences.
13 being used by the institutions to teach the basic sciences.
14 ation through its use in the teaching of the basic sciences.
15 experimental approaches in the clinical and basic sciences.
16 o generate a convergence between applied and basic sciences.
17 llaboration patterns between the applied and basic sciences.
18 rofessional stakeholder groups, and clinical/basic science academicians, recommendations were made on
19 goals are to build a contiguous bridge from basic science, accelerate the advancement of promising p
21 mportant recent clinical, epidemiologic, and basic science advances within this area of rheumatology.
22 y of PBC in the 2000s has been buoyed by two basic science advances: rapid sequencing technologies th
29 made for future research priorities for both basic science and clinical application of emerging thera
30 indings, and discuss the challenges for both basic science and clinical applications in the continued
32 tterns in B cell Ig sequences have important basic science and clinical applications, but they are of
35 in the field of Alzheimer's disease (AD) for basic science and clinical applications; however, the bi
36 ring of ideas among participating experts in basic science and clinical aspects of allergic diseases
37 ytes (TIL) is increasingly important in both basic science and clinical aspects of breast cancer rese
41 may provide data complementary to that from basic science and clinical intervention studies, all of
44 technology would enable a whole new class of basic science and clinical MRI experiments that simultan
46 ings in humans has broad applications within basic science and clinical practice beyond DBS, offering
47 the past 3 years, numerous breakthroughs in basic science and clinical research have been made, augm
51 s that have aimed to accomplish this in both basic science and clinical settings and follow the gener
56 eview summarizes the past year's literature, basic science and clinical, regarding the neural, paracr
59 the potential for empowering applications in basic science and enhancing our understanding of the act
61 review, we discuss the implications both for basic science and for targeting glutamine metabolism in
63 al for developing models that can be used in basic science and medicine, to aid in predicting cells f
66 statin protection against OAG including both basic science and observational clinical studies, an int
68 s from radiology, hepatology, pathology, and basic science and physics to arrive at a consensus regar
69 be used to manipulate cytokine signaling for basic science and possibly for therapeutic applications.
71 ertook a detailed review of data from recent basic science and preclinical studies to investigate the
72 too difficult to tackle have benefited from basic science and technological advances over the past d
74 ries, the wisdom of the West of investing in basic science and technology led to its dominance in wor
75 easons: first, the intellectual curiosity of basic science and the desire to understand fundamental p
76 me suggest significant implications for both basic science and the development of novel biomarkers/di
77 active motifs because of their importance in basic science and their broad utility in medicine and bi
81 iated virus (rAAV) is an attractive tool for basic science and translational medicine including gene
82 oding DNA can have enormous benefit for both basic science and translational research because over 98
84 g is an independent review that analyzes the basic science and translational strategies supporting th
85 Time- and dose-to-event phenotypes used in basic science and translational studies are commonly mea
86 ss time than FACS may prove valuable in both basic science and translational, cell-based applications
88 d have wide applications to glycoproteins in basic sciences and industry because no apparent bias for
89 clinical findings, pathology, epidemiology, basic science, and risk-management issues associated wit
91 apacity in living cells is valuable for both basic science applications and epidemiological studies,
97 e disorders in recent years, and advances in basic science are being translated into increasing numbe
98 ponential increase was seen in the number of basic science articles (P < .001), review articles (P <
99 computer science, new imaging technique, and basic science articles were considered "preclinical." Us
100 Thus, HistoMosaic has wide applicability in basic science as a tool to map genetic heterogeneity.
101 oung researchers are crucially important for basic science as they make unexpected, fundamental disco
102 antification of FC and CE in samples used in basic science as well as clinical studies such as cultur
103 Psychiatry has similarly emphasized the basic sciences as the starting point of translational re
105 anticipate that these results, besides most basic science aspects, hold the potential for numerous a
108 epeat) systems have been broadly adopted for basic science, biotechnology, and gene and cell therapy.
109 of research has been primarily practiced in basic science but has recently been extended to clinical
110 ADME processes in humans and is relevant to basic science, clinical medicine and pharmaceutical rese
111 omposed of researchers with expertise in the basic science, clinical science, and epidemiological asp
112 tutes, the workshop addressed epidemiologic, basic science, clinical, and translational issues in can
113 published literature and expert opinion, the Basic Science Committee of the Society of University of
115 n is thought to improve the understanding of basic science conceptual knowledge and to better prepare
121 clinical trials, translational research, and basic science demands that investigators in the field us
122 cy, and medicine and have worked in multiple basic science departments and one clinical department.
123 ed as assistant professors in medical school basic science departments was not related to the number
125 pace in clinical departments but declines in basic science departments; and research is judged more o
128 essing the epidemic will require advances in basic science, development of more acceptable and effect
130 late the immune system continue to emerge as basic science discoveries are made, including the use of
132 the demand for more effective translation of basic science discoveries into new clinical applications
134 functional specialization; integrating these basic science discoveries with clinical efforts will sup
135 connect in the translational process between basic science discovery, early drug development, and def
137 ate that simulation is an effective tool for basic science education and garners high learner satisfa
138 then, continued cross-fertilization between basic science efforts and clinical endeavors has highlig
139 e view from different disciplines, including basic science, epidemiology, bioinformatics, and network
145 d an explosion in studies--both clinical and basic science--examining the relationship between the mi
146 ns have been described and modeled both as a basic science exercise and for a range of applied goals
147 use as nanotools and reagents in a range of basic science, experimental therapeutic and clinical app
148 steady drop in the number of grant-eligible basic-science faculty [principal investigators (PIs)] yo
153 ing needs, in turn, require mission-oriented basic science, for example about potential signposts and
155 ovation and the high-profile achievements of basic science generated in academic and biomedical labs.
156 y of the epidermis and, in turn, progress in basic science has informed our understanding of disease.
161 s, and pathology), clinical research, and/or basic science in the areas of PH identified important qu
166 late the biologic-mechanistic knowledge from basic science into efficacious treatments able to improv
167 ponsible for SCD has emerged from decades of basic science investigation into the normal electrophysi
169 nformation that is valuable for clinical and basic science investigations of cancer but extracting qu
170 r many applications, whether the focus is on basic science investigations or therapeutic efficacy, ac
171 reviews, prospective randomized trials, and basic science investigations, were identified in a PubMe
173 presented here is instructive to clinicians, basic science investigators, and policy makers who deter
174 ed in moving from being Editor-in-Chief of a basic science journal to the same position at Annals of
175 l biomedical engineering journals, and the 5 basic science journals with the highest impact factor, w
177 d tissue, preoperative neuroimaging, and the basic science laboratory suggest that the syndrome is no
178 and later life outcomes at a mechanistic and basic science level, it is important to understand the p
180 cripts (0.94 vs. 1.67, p < 0.05), as well as basic science manuscripts (0.21 vs. 0.54, p < 0.05) and
181 sed materials, with numerous applications in basic science, materials engineering, and biotechnology.
183 choice of anti-inflammatory agent given the basic science mechanisms and epidemiologic results that
186 r the MA are taking up new challenges in the basic science needed to assess, project, and manage flow
188 avenues to advance OPV technologies and the basic science of charge transfer in organic semiconducto
189 r materials could contribute not only to the basic science of fullerene chemistry but would also be u
190 has two major objectives: first, to sketch a basic science of intentional change centered on evolutio
191 "translational nanotechnology" as it bridges basic science of nanomaterials with practical applicatio
193 how that this issue is deeply related to the basic science of soft matter, especially to the viscosit
196 PubMed databases from inception to 2013 for basic science or clinical studies relating to genetic as
197 f the BPH literature with a special focus on basic science or translational studies concerned with th
198 in use today, research has tended to be more basic-science oriented rather than commercially applicab
199 ed by article type (clinical, population, or basic science; P=0.19), whether an article had an editor
200 Jak/STAT research has not only impacted basic science, particularly in the context of intercellu
201 elucidate these complex circuits both from a basic science perspective and in the context of psychiat
202 hese rich phenomena are fascinating from the basic science perspective and offer possibilities for te
204 y relevant and of particular interest from a basic sciences perspective due to the complex nature of
205 aused the steady drop in the number of young basic-science PIs and could reduce future US discoveries
206 this time, the PI success ratio (fraction of basic-science PIs who are R01 grantees) dropped for youn
208 article explores the latest developments in basic science presented at the Congress which may offer
209 hlights how translation of these advances in basic science promises to change clinical practice.
210 at recent young surgeons published 59% fewer basic science publications (IRR 0.41, 95% CI 0.29-0.57,
211 rating that statistical errors are common in basic science publications have led to calls to improve
213 sional training of cancer researchers in the basic sciences rarely involves interactions with patient
214 summarizing progress in clinical trials and basic science redefining the diagnosis and treatment of
215 prospective randomized clinical trials, and basic science reports, were identified in a PubMed searc
216 decline in the number of surgeons performing basic science research alongside clinical activity - so-
219 esearch faculty, 33.6% exclusively conducted basic science research as principal investigators compar
220 ts in this field that are paving the way for basic science research discoveries to transition to clin
222 For the greater part of the last century, basic science research has been limited to in vitro stud
225 e challenges confronting surgeons performing basic science research in today's academic surgery envir
227 hey had a good understanding for translating basic science research into clinical practice, and 77.2%
229 rgeted agents for therapeutic use, much more basic science research is required before we fully under
232 Owing to relatively rapid translation of basic science research on a novel regulatory pathway of
233 urope, and Australia engaged in clinical and basic science research on ALPS and related disorders.
235 tiary PAH centers often support clinical and basic science research programs to gain novel insights i
238 ove their communication skills by explaining basic science research to a general audience, and studen
240 reatment will require a rapid translation of basic science research, and the simultaneous development
241 eated; opportunities for proteomics to drive basic science research, facilitate clinical translation,
243 espread use in both clinical diagnostics and basic science research, nearly all methods require direc
244 d 9 technology, the impact on cardiovascular basic science research, possible therapeutic application
245 ng to encourage participation of surgeons in basic science research, translational research, clinical
251 cation of knowledge generated by advances in basic sciences research translated into new approaches f
252 earchers were significantly more likely than basic science researchers (41.9%) to report a relationsh
253 trainees; pharmacists; and translational and basic science researchers from the Pediatric Acute Lung
254 red, a proportion that ranged from 11.5% for basic science researchers to 46.8% for health services r
255 the field, and propose ways to translate the basic science results as well as the mechanistic underst
256 ory of T1 translational research-translating basic science results into new interventions-and T2 tran
258 he increasing use of RNA-seq in clinical and basic science settings provides a powerful opportunity t
262 le to translate the discoveries derived from basic science studies into the clinical care of the pati
267 his timely review will focus on clinical and basic science studies that have greatly advanced our kno
270 vides a realistic human cell based model for basic science studies, identification of new treatment t
273 putational reinforcement-learning models and basic-science studies of the dopamine system, we show th
274 ging evidence from epidemiologic studies and basic science suggests an inverse association between me
275 diagnosis of prostate cancer, highlight the basic science supporting this role, and analyze the phas
278 nd cellular specificity has been greater for basic science than clinical research, it is natural to a
279 S: This review will focus on two advances in basic science that are now translating into clinical tri
281 arly-stage translation of the discoveries in basic science, the National Institutes of Health and the
288 eries and innovations move from the realm of basic science to preclinical and clinical applications,
292 Promising advances are being translated from basic science to the clinic, including approaches to dis
294 education, specifically, the teaching of the basic sciences to accomplish the goal of improved integr
297 ortion of academic surgeons who are pursuing basic science/translational research, which represents a
299 e discoveries emphasize the critical role of basic science, which often evolves in unpredictable and